LEIDY CARABALLO GALVA to Mice
This is a "connection" page, showing publications LEIDY CARABALLO GALVA has written about Mice.
Connection Strength
0.071
-
Novel low-avidity glypican-3 specific CARTs resist exhaustion and mediate durable antitumor effects against HCC. Hepatology. 2022 08; 76(2):330-344.
Score: 0.058
-
Preclinical Studies of the Off-Target Reactivity of AFP158-Specific TCR Engineered T Cells. Front Immunol. 2020; 11:607.
Score: 0.013